Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.

MLA

Mori, Keiichiro, et al. “Prognostic Value of Preoperative Blood-Based Biomarkers in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.” Urologic Oncology, vol. 38, no. 5, May 2020, pp. 315–33. EBSCOhost, https://doi.org/10.1016/j.urolonc.2020.01.015.

APA

Mori, K., Janisch, F., Mostafaei, H., Lysenko, I., Kimura, S., Egawa, S., & Shariat, S. F. (2020). Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis. Urologic Oncology, 38(5), 315–333. https://doi.org/10.1016/j.urolonc.2020.01.015

Chicago

Mori, Keiichiro, Florian Janisch, Hadi Mostafaei, Ivan Lysenko, Shoji Kimura, Shin Egawa, and Shahrokh F Shariat. 2020. “Prognostic Value of Preoperative Blood-Based Biomarkers in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.” Urologic Oncology 38 (5): 315–33. doi:10.1016/j.urolonc.2020.01.015.